The acquisition follows TJP’s previous integration of FX2 Virtual, which added virtual sales professionals and omnichannel analytics to the firm’s offerings. By absorbing Evolution Consulting—a firm focused on qualitative and quantitative market insights—TJP now controls a full-stack engine spanning research, strategy, creative development, and field pull-through. This consolidation aims to help biotechnology and pharmaceutical companies navigate increasingly complex pricing and market access environments.

Rino Mariconda, CEO of TJP and Operating Partner at Renovus Capital, noted that the move transforms the firm from a strategy-focused agency into a comprehensive commercial partner. According to Mike Heasley, Partner at Evolution Consulting, the integration ensures that data-driven insights directly inform creative campaigns and commercial deployment, reducing the friction often found when working across multiple vendors. The expanded platform is designed to optimize brand performance and accelerate patient access to therapies by harmonizing primary research with real-world sales execution.